NCT02051101

Completed

Pathogenic Mechanisms of Port Wine Stain and Repository of P...

University of California, Irvine Source

Compare

Other study identifiers

Sponsor study identifier

20139396

Study Type

interventional

Actual enrollment (reported)

19

Locations

1 country

Sites

1

Timeline

Study Start

April 23, 2013

Actual (reported)

Primary Completion

January 11, 2019

Actual (reported)

Study Completion

January 11, 2019

Actual (reported)

Brief Summary

The purpose of this study is to investigate the pathogenic mechanisms of Port Wine Stain, collect biopsy samples and blood samples to characterize exosomes and metabolites from Port Wine Stain.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 19 participants
Study completion date: January 11, 2019
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
April 23, 2013
Actual (reported)
First Submitted
November 6, 2013
Actual (reported)
First Posted
January 31, 2014
Actual (reported)
Primary Completion
January 11, 2019
Actual (reported)
Study Completion
January 11, 2019
Actual (reported)

Last Updated: November 1, 2022
Status Verified: October 2022
Last Update Submitted: October 28, 2022

Conditions

Port-Wine Stain

Outcome Measures

Primary Outcomes (1)

Characterization of Port Wine Stain Birthmark tissue sample
up to 4 weeks

Study Arms (1)

Port Wine Stain Birthmark

OTHER

Biopsy sample from Port Wine Stain Birthmark

Other: Biopsy sample from Port Wine Stain Birthmark

Interventions

Biopsy sample from Port Wine Stain BirthmarkOther

Biopsy sample from Port Wine Stain Birthmark

Port Wine Stain Birthmark

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age1 Day+

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

Male or female of all ages.
Not pregnant.

Sponsors & Collaborators

Beckman Laser Institute University of California Irvine
Othercollaborator
University of California, Irvine
Otherlead

Study Sites (1)

Beckman Laser Institute

Irvine, California, 92612, United States

MeSH Terms

Conditions

Port-Wine Stain

Condition Hierarchy (Ancestors)

Skin AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

John s Nelson, MD
Beckman Laser Institute, UCI
STUDY DIRECTOR
Winbin Tan, PhD
Beckman Laser Institute
PRINCIPAL INVESTIGATOR

Enrollment

19 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: BASIC SCIENCE
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Wenbin Tan, Ph.D. Project Scientist

Study Record Dates

First Submitted

November 6, 2013

First Posted

January 31, 2014

Study Start

April 23, 2013

Actual (reported)

NCT07183644

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

Not ApplicableRecruiting

NCT00782483

Personalized Interactive Laser Therapy of Port Wine Stain

Not ApplicableTerminated

NCT04103164

Pilot Study to Evaluate the Effect of Multiple Passes on Port Wine Stain Treatments With the Cutera Excel V™ Laser.

Not ApplicableSuspended

NCT01774552

Evaluate the Port-wine Stain Birthmark Treatment Before and After Pulsed Dye Laser Treatment

Completed

NCT02214706

Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus

Not ApplicableTerminated

NCT01924273

Novel Treatment for Port Wine Stain Birthmarks

Phase 1Completed

Has diagnosis of port wine stain on the arms, legs, chest, bac.

Ability to understand and carry out subject instructions.

Subject willing to have skin biopsies on port wine stain and normal skin areas.

You may not qualify if:

Pregnant women.
Port Wine Stain on the face.
History of skin cancer.
Current participation in an investigational drug evaluation
Concurrent use of known photosensitizing drugs.

Contact the study team to confirm eligibility.

Primary Completion

January 11, 2019

Actual (reported)

Study Completion

January 11, 2019

Actual (reported)

Last Updated

November 1, 2022

Record last verified: 2022-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT02051101
Data provider: ClinicalTrials.gov
Source updated: 2022-11-01
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:26:33 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Port Wine Stain Birthmark

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations